C-reactive protein and risk of cardiovascular disease: evidence and clinical application (Q35197097)

7 August 2017

1 reference

title

C-reactive protein and risk of cardiovascular disease: evidence and clinical application (English)

1 reference

7 August 2017

cardiovascular disease

1 reference

1

Paul M Ridker

1 reference

7 August 2017

3

Peter P Toth

1 reference

7 August 2017

Shari S Bassuk

2

1 reference

7 August 2017

1 September 2003

1 reference

Current Atherosclerosis Reports

7 August 2017

1 reference

7 August 2017

5

1 reference

7 August 2017

5

1 reference

7 August 2017

341-349

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-003-0004-3

7 August 2017

0 references

cites work

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Infections, inflammation, and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Is C-reactive protein specific for vascular disease in women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0004-3

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

12 December 2020

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

1 reference

12 December 2020

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

C-reactive protein and myocardial infarction

1 reference

12 December 2020

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

1 reference

12 December 2020

Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels

1 reference

12 December 2020

C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Inflammation and cardiovascular risk in dialysis patients.

1 reference

12 December 2020

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

1 reference

12 December 2020

Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women

1 reference

12 December 2020

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

1 reference

12 December 2020

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

1 reference

12 December 2020

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

12 December 2020

Progression of atheroma: a struggle between death and procreation

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

12 December 2020

Inflammation and atherosclerosis

1 reference

12 December 2020

C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

1 reference

12 December 2020

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

1 reference

12 December 2020

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

1 reference

12 December 2020

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

1 reference

12 December 2020

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

1 reference

12 December 2020

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

1 reference

12 December 2020

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

1 reference

12 December 2020

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Population Distribution of High-Sensitivity C-reactive Protein among US Men: Findings from National Health and Nutrition Examination Survey 1999-2000

1 reference

12 December 2020

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

1 reference

12 December 2020

10.1007/S11883-003-0004-3

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12911843